www.fdanews.com/articles/177804-seegene-debuts-automated-development-for-molecular-testing-devices
Seegene Debuts Automated Development for Molecular Testing Devices
August 3, 2016
Seegene has developed a in silico-based solution for automated development of molecular testing devices, the company revealed Wednesday.
The automated solution can reduce assay development time significantly, down to less than a week.
By using an in silico-based development solution, Seegene has found a way to simplify the process of real-time PCR assay development and is looking to expand its use in molecular diagnostics, the company disclosed. — Cynthia Jessup